A recombinant Borrelia burgdorferi flagellin protein expressed in Escherichia coli is bound by a murine monoclonal antiflageilin antibody (H9724) and by antibodies in the sera of patients with Lyme disease. Immunoreactive epitopes on the flagellar protein were identified by immunoblot analysis of antibody binding to expressed truncated flagellar proteins. The epitope recognized by the murine monoclonal antibody is within the central heterologous region of the flagellar protein (amino acids 90 to 266). However, antiflagellin antibodies in the sera of patients with Lyme arthritis bound an epitope entirely within, or whose conformation was partly formed by, the 90 NH2-terminal amino acids of the flagellar protein. The binding of antibodies in the sera of patients with Lyme arthritis to the NH2-terminal region of the flagellar protein, a region with sequence homology to the flagellar proteins of other bacterial species, suggests the possibility that antigenic mimicry contributes to the immunopathogenesis of Lyme disease. The fact that human antibodies bind to a highly conserved and hence shared portion of the flagellin reduces the specificity of serological assays for the diagnosis of Lyme disease which use the flagellar protein as antigen.
Since the tick-borne spirochete that causes Lyme disease, Borrelia burgdorferi, has been identified (7) and can be cultured in vitro (2) , Lyme disease is an ideal system for studying the molecular mechanisms underlying human chronic inflammatory diseases. It is our hypothesis that the inflammation that produces organ damage in patients with Lyme disease is initiated and possibly perpetuated by the immune response to one or more spirochetal proteins. Therefore, important insight into the immunopathogenesis of Lyme disease should be obtained from the characterization ofBorrelia proteins which induce B-cell and T-cell responses in patients with Lyme disease.
The 41-kDa flagellar protein of B. burgdorferi is an immunodominant spirochetal antigen. It is the first spirochetal protein to trigger a humoral immune response, and antiflagellar antibodies persist in the sera of Lyme disease patients throughout the course of the disease (5, 11) . It has also been suggested that serodiagnostic tests for Lyme disease may be improved through the use of flagellinenriched protein fractions (9, 14) . The isolation of a cloned T cell reactive with the flagellar protein from the synovial fluid of a patient with Lyme arthritis (27) indicates that flagellar antigens are capable of stimulating a cellular immune response as well. Because the Borrelia flagellin is a potent immunogen for the human immune system, and therefore may play a role in the pathogenesis of Lyme disease, we have analyzed the epitopes on the flagellar protein that trigger an immune response in patients with Lyme arthritis. Expressed recombinant full-length and truncated flagellar proteins were prepared and used in this analysis.
MATERIALS AND METHODS Antibodies. The murine immunoglobulin G2a monoclonal antibody, H9724, which is specific for Borrelia flagellins (6) , was obtained as a culture supernatant from Alan Barbour. This antibody was filtered through a 0.22-,um-pore-size filter prior to use at a dilution of 1:100 for immunoblotting. The * Corresponding author. sera used in this study were obtained from patients with clinical histories consistent with Lyme disease, including a clinically apparent arthritis developing after a tick bite and lasting at least 1 year and a high titer of serum antibodies to B. burgdorferi proteins as determined by an enzyme-linked immunosorbent assay (ELISA). Lyme disease serum 4 (LDS4) was prepared from a male from northern California with chronic Lyme arthritis whose clinical course was previously described (22) . LDS5, LDS6, and LDS7 are representative of sera obtained from five patients from the Long Island, N.Y., area (supplied by David Volkman, The State University of New York at Stony Brook, Stony Brook, N.Y.). These patients presented with arthritis and had a prior history of tick bite and skin rash and a serology consistent with chronic Lyme arthritis. LDS8 was obtained from a 17-year-old male residing in northern California. Four years previously, he had experienced a tick bite and subsequently developed a skin rash that was not diagnosed at the time of presentation. Several months later he developed an asymmetric intermittent oligoarthritis, primarily involving the knees. The arthritis persisted for 2 years prior to evaluation by a rheumatologist. Evaluation in 1985 revealed a negative rheumatoid factor and MHA-TP; synovial fluid aspirate had 7,500 leukocytes (75% polymorphonuclear) with no bacteria or crystals. The diagnosis of Lyme arthritis was confirmed when serum antibody reactivity with Borrelia proteins in an ELISA (immunoglobulin G index, >2) was shown. After treatment with a 10-day course of intravenous penicillin in March 1986, he experienced total resolution of his arthritis. The remainder of the sera used in this study were supplied by rheumatologists in the northern California area. All of these sera were from patients who had clinical histories, including the development of arthritis after a tick bite, and serologies consistent with Lyme arthritis. Control sera were prepared from blood obtained from healthy individuals, 23 Total RNA, isolated from a culture of the CA12 isolate (8), was reverse transcribed (17), using Flagll as the oligonucleotide primer. The full-length and truncated flagellin genes were amplified from the resulting cDNA, using the following pairs of oligonucleotide primers: plasmid p41-1, oligonucleotide primers Flag9 and Flagll; p41-4, Flag26 and Flag27; p41-5, Flag9 and Flag27; p41-6, Flag26 and Flagll. Thirty cycles of amplification were performed using a thermal cycler and reagents according to the manufacturer's instructions (Perkin-Elmer-Cetus, Norwalk, Conn.) with the following cycle parameters: 1 min at 94°C for denaturation, 2 min at 45°C for annealing, and 3 min at 65°C for extension. The amplified DNA was extracted with phenol-chloroform, ethanol precipitated, and digested with EcoRI and PstI restriction enzymes, and the product was isolated from a 1% agarose gel in Tris-acetate buffer. The purified DNAs were ligated into the procaryotic expression plasmid pKK223-3 (Pharmacia, Piscataway, N.J.) and digested with the same restriction enzymes prior to transformation of E. coli JM109 (Stratagene, La Jolla, Calif.).
Cultures of E. coli JM109 transformed with pKK223-3 or the flagellin-encoding plasmids were induced with 3 mM isopropyl-p-thiogalactopyranoside (U.S. Biochemicals, Cleveland, Ohio) for 3 h prior to being harvested by centrifugation. The harvested bacterial pellets were placed in SDS-PAGE sample buffer with P-mercaptoethanol for analysis of the expressed proteins. The expressed recombinant flagellin proteins were partially purified by lysis of the bacterial pellets by sonication with a model W-375 sonicator (Ultrasonics, Farmingdale, N.Y.) for 10 min, at 50% cycle, setting no. 5, and 4°C. The material pelleting after centrifugation at 12,000 x g for 5 min, containing the expressed proteins, was resuspended in SDS-PAGE sample buffer.
The nucleotide sequence of the entire flagellin gene in p41-1, as well as the 5' and 3' ends of p41-4, p41-5, and p41-6, was determined by using the dideoxy method with modified T7 DNA polymerase (Stratagene).
Immunoblotting. One-dimensional SDS-PAGE separation of proteins was performed as previously described (23) antibody by using alkaline phosphatase-conjugated goat antihuman (or anti-mouse) immunoglobulin G (Bio-Rad Laboratories, Richmond, Calif.) were performed by following the instructions of the manufacturer. burgdorferi lysate (Fig. 2) . This protein is not found in lysates of E. coli transfected with the expression plasmid without the flagellin gene inserted (Fig. 2) . A murine monoclonal antibody, H9724 (6), specific for Borrelia flagellar protein, bound the expressed recombinant protein, confirming that p41-1 encodes the flagellar protein of B. burgdorferi (Fig. 2) .
Sera from 15 patients with Lyme disease, with a high titer of anti-Borrelia antibodies as determined by an ELISA, were tested for binding to the expressed recombinant flagellar protein by immunoblotting. All of the sera from the Lyme disease patients had antibodies reactive with the recombinant flagellar protein ( Fig. 2A) LGMQPAKINTPASLSGSQASWTLRVHVGANQDEAIAVNIYAANVANLFSG .
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.__________________-. Fig. 2B ). However, antibodies in three of the control sera bound, to a lesser extent than antibodies in the sera of Lyme arthritis patients, both expressed recombinant and native Borrelia flagellin (representative blots in Fig. 2B ).
-------------
The amino acid sequence of the flagellin of the CA12 isolate has 99% identity with that of other B. burgdorferi isolates. The nucleotide and predicted amino acid sequences of the cDNA encoding the flagellar protein of the CA12 isolate of B. burgdorferi, originating from the western United States, were determined (Fig. 3) . The nucleotide sequence differed from that of the B31 (13) Glu-111llGln-111, Gly-171--Trp-171, Thr-180--Asn-180, and Asn-279-->Asp-279 (Fig. 3) . A comparison of the amino acid sequence of the CA12 flagellin with that of a European B. burgdorferi isolate, GeHo (13) , revealed alternate residues at only two additional positions (GeHo-+CA12): Lys-160-*Thr-160 and Val-259--Met-259.
Immunoreactive domains identified by using expressed recombinant truncated flagellar proteins. Recombinant plasmids encoding truncated B. burgdorferi flagellar proteins were prepared and expressed in E. coli to identify the regions containing the antibody-reactive epitopes. p41-4 encodes amino acids 90 to 266, p41-5 encodes amino acids 1 to 266, and p41-6 encodes amino acids 90 to 336 of the Borrelia flagellar protein (Fig. 4) . SDS-PAGE analysis of lysates of E. coli expressing the recombinant truncated flagellar proteins is shown in Fig. 5 . An abundantly expressed protein with a relative mobility of 30 kDa, consistent with the predicted molecular mass of the recombinant truncated flagellin, was seen in lysates of E. coli transfected with p41-5 but was not found in control E. coli lysates (Fig. 5) .
Lysates of E. coli transfected with p41-4 and p41-6 did not contain expressed proteins at levels detectable with the Coomassie blue stain. However, immunoblotting demonstrated that expressed proteins reactive with the murine monoclonal antiflagellar antibody H9724 were present in lysates of E. coli transfected with p41-4, p41-5, and p41-6 (Fig. 5) . The relative mobility of the antibody-reactive truncated flagellar proteins encoded by p41-4 and p41-6 on SDS-PAGE differed from their predicted molecular mass, probably as a result of aggregation with other E. coli proteins. After partial purification by centrifugation of sonicated bacterial lysate, the relative mobility of the flagellar proteins was consistent with their predicted molecular mass (Fig. 6) . The presence of more than one antibody-reactive protein band in the lysates containing the p41-4-and p41-6-encoded proteins may have resulted from proteolytic degradation (Fig. 6) . Therefore, the epitope recognized by the monoclonal antibody H9724 was localized to the region between amino acids 90 and 266 of the flagellar protein.
In contrast, antiflagellin antibodies in the sera of Lyme
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disease patients recognized an epitope in a different region of the B. burgdorferi flagellar protein. The antibodies in the sera of all nine of the Lyme disease patients examined bound the truncated expressed flagellar protein encoded by p41-5 to the same extent as the full-length recombinant flagellar protein but did not bind to the p41-4-or p41-6-encoded proteins (representative data in Fig. 5 ). This indicates that antiflagellin antibodies in the sera of patients with Lyme arthritis bound an epitope entirely within, or whose conformation was partly formed by, the 90 NH2-terminal amino acids of the flagellar protein. (23), Salmonella typhimurium (St) (14) , and E. coli (Ec) (18 inflammatory arthritis. Therefore, the observation that the human and murine humoral immune response to the immunodominant spirochetal protein is directed against different epitopes is of potential pathogenic significance. The NH2-terminal and COOH-terminal domains of flagellins from various bacterial species and strains are highly homologous (10, 16 ) and appear to be essential for the assembly of the flagellar filament (15, 19) . There is more heterogeneity in the amino acid sequences in the central region of the flagellar proteins of different bacterial species, and antibody-reactive epitopes are usually located in this region (18, 21, 25, 26) . The binding of antibodies in the sera of Lyme arthritis patients to an epitope in the NH2-terminal domain of the Borrelia flagellar protein, which has significant sequence homology with the flagellar proteins of other bacterial species (Fig. 7) , raises the possibility that antigenic mimicry (24) (22) noted that use of a spirochetal protein fraction which lacked the flagellin as antigen improved the specificity of an ELISA for serum immunoglobulin G binding when compared with whole Borrelia protein as antigen. Therefore, the specificity of serodiagnostic tests may be improved if other recombinant proteins which are both immunoreactive and more specific for this pathogen are utilized.
